Maxime Van Houdt

Leuven, VLG 3000, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Patient Preferences in Breast Cancer: A Scoping Review.

Patient Preferences in Breast Cancer: A Scoping Review.

Journal: Cancers

Published: November 24, 2025

A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study.

A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study.

Journal: ESMO open

Published: July 07, 2025

Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries.

Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries.

Journal: medRxiv : the preprint server for health sciences

Published: March 17, 2025

(Intravascular) papillary endothelial hyperplasia or Masson's tumour of the axilla in a patient with a history of breast cancer.

(Intravascular) papillary endothelial hyperplasia or Masson's tumour of the axilla in a patient with a history of breast cancer.

Journal: BMJ case reports

Published: November 12, 2024

Navigating next-generation HR+/HER2- metastatic breast cancer therapies: a critical commentary on abemaciclib vs. tucidinostat after palbociclib progression.

Navigating next-generation HR+/HER2- metastatic breast cancer therapies: a critical commentary on abemaciclib vs. tucidinostat after palbociclib progression.

Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer

Published: August 01, 2023

RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish Observational Cohort Study.

RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish Observational Cohort Study.

Journal: Journal of the National Cancer Institute

Published: February 24, 2023

Measurable Serum Estradiol and Estrone in Women 36-56 Years During Adjuvant Treatment With Aromatase Inhibitors for a Hormone Receptor-Positive Breast Cancer. Case Studies and Cross-sectional Study Using an Ultra-sensitive LC-MS/MS-Method.

Measurable Serum Estradiol and Estrone in Women 36-56 Years During Adjuvant Treatment With Aromatase Inhibitors for a Hormone Receptor-Positive Breast Cancer. Case Studies and Cross-sectional Study Using an Ultra-sensitive LC-MS/MS-Method.

Journal: Clinical breast cancer

Published: November 21, 2021

Prenatal 3D-ultrasound diagnosis of isolated intrahepatic portal-systemic shunt with intact ductus venosus: A case report and literature review.

Prenatal 3D-ultrasound diagnosis of isolated intrahepatic portal-systemic shunt with intact ductus venosus: A case report and literature review.

Journal: Radiology case reports

Published: January 24, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026